Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Lauren Buchanan
Advertisement
Articles by Lauren Buchanan
The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
2
ACIP's Vacancy Leaves Pharmacists Navigating COVID-19 Confusion
3
Tirzepatide Receives Expanded Approval for MACE in Patients With T2D
4
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
5